Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1379)
  2. Journal Article (1159)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Correspondence (26)
  7. Book Section (25)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Hematology-Oncology Fellows (2763)
  2. Department of Medicine (2720)
  3. Solid Tumor Oncology Division (2017)
  4. Hematologic Malignancies, Division of (1337)
  5. GSK Faculty (1233)
  6. Department of Pathology and Laboratory Medicine (988)

More Groups

People
  1. Michael Berger (220)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (177)
  5. Sergio Giralt (171)
  6. David Solit (169)

More People

Years
  1. 2025 (223)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (645)
  2. Elsevier Inc. (344)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (241)
  5. Nature Publishing Group (202)
  6. Oxford University Press (157)

More Publishers

Results (2836)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mis-splicing derived neoantigens and cognate T cell receptors in splicing factor mutant myeloid neoplasms
    Meeting Abstract

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E.; Wang, E.; Bewersdorf, J. P.; Lu, S. X.; Belleville, A.; Fox, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Single-agent mosunetuzumab produces high complete response rates in patients with newly diagnosed follicular lymphoma: Primary analysis of the MITHIC-FL1 trial
    Meeting Abstract

    Falchi, L.; Okwali, M.; Ferreira Lopes, A.; Hamlin, P. A.; Lue, J. K.; Ghione, P.; Owens, C.; Torka, P.; Kumar, A.; Steiner, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Assessing role of comorbidities in treatment selection for older patients with acute myeloid leukemia
    Meeting Abstract

    Grenet, J.; Easwar, N.; Jain, A. G.; Burkart, M.; Ma, X.; Christos, P.; Ritchie, E. K.; Samuel, M.; Kaner, J. D.; Canaani, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The prognostic and predictive value of RUNX1 mutations in newly diagnosed acute myeloid leukemia - An international multicenter cohort study
    Meeting Abstract

    Bystrom, R. P.; Bewersdorf, J. P.; Liu, Y.; Schaefer, E. J.; Shallis, R. M.; Boussi, L.; Zucenka, A.; Garciaz, S.; Aguirre, L. E.; DeAngelo, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genomic determinants of resistance to anti-BCMA chimeric antigen receptor T-cell (CART) therapies in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Maura, F.; Freeman, C. L.; Lee, H.; Maclachlan, K. H.; Durante, M.; Ziccheddu, B.; Menges, M.; Diamond, B.; Papadimitriou, M.; Silva, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes following progression of disease post-CAR-T therapy in relapsed or refractory mantle cell lymphoma: A multicenter analysis
    Meeting Abstract

    Epstein-Peterson, Z. D.; Lionel, A. C.; Joseph, A.; Drill, E.; Atallah-Yunes, S. A.; Brooks, T. R.; Chong, E. A.; Chong, E. R.; Dela Cruz, J.; Frank, M. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Surgical outcomes and genomic insights of nonclear cell renal cell carcinoma with synchronous and metachronous nodal disease
    Journal Article

    Eismann, L.; Zucker, M.; Dawidek, M. T.; Reese, S. W.; Calderon, L. P.; Aulitzky, A.; Stief, C. G.; Coleman, J. A.; Kotecha, R. R.; Carlo, M.; more...
    Urology Practice (2024)

    Fulltext@MSK | Save
  • A phase 2, open-label, single-arm, prospective, multicenter study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Musa, F.; Mathews, C.; Spirtos, N.; Slomovitz, B.; Priebe, A.; Green, A.; Puechl, A.; Birrer, M.; Herzog, T.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Upgrade: Phase 1 trial of the NaPi2b-directed dolaflexin antibody drug conjugate UpRi in combination with carboplatin in patients with platinum-sensitive ovarian cancer (PSOC)
    Meeting Abstract

    Friedman, C.; Anderson, C.; Hays, J.; Lakhani, N.; Buscema, J.; Hamilton, E.; Taylor, S.; Duska, L.; Cloven, N.; Reske, A.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save